Tango Therapeutics, Inc. (TNGX) has 4 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 3, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 3, 2026 filed Sept. 1, 2026 | Crystal Adam President, R&D | $463,509 | 81,000 | 0% | Yes | |
|
|
||||||
| Aug. 5, 2026 filed Aug. 3, 2026 | Crystal Adam President, R&D | $595,117 | 81,000 | 0% | Yes | |
|
|
||||||
| July 2, 2026 filed July 1, 2026 | Crystal Adam President, R&D | $658,508 | 81,000 | 0% | Yes | |
|
|
||||||
| June 23, 2026 filed June 19, 2026 | Azelby Robert Director | $0 | 41,650 | +19% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free